Filing Details

Accession Number:
0000950170-25-015473
Form Type:
13G Filing
Publication Date:
2025-02-05 19:00:00
Filed By:
Vensana Capital I GP, LLC
Company:
Cvrx Inc.
Filing Date:
2025-02-06
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Vensana Capital I GP, LLC 0 1,711,355 7.1%
Vensana Capital I, L.P. 0 1,711,355 7.1%
Kirk Nielsen 0 1,760,734 7.2%
Peter Justin Klein 0 1,711,355 7.1%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by Vensana I (as defined in Item 2(a) of the Original Schedule 13G (as defined in Item 2(a) below)). Vensana GP I (as defined in Item 2(a) of the Original Schedule 13G) is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 24,263,663 shares of Common Stock (as defined in Item 2(d) of the Original Schedule 13G) outstanding as of October 25, 2024, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission (the "Commission") on November 1, 2024 (the "Form 10-Q").


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares of Common Stock reported in rows 5 and 7 are subject to stock option awards that have been granted to Kirk Nielsen in his capacity as a director of the Issuer and that are exercisable as of or within 60 days of filing this Amendment (as defined in Item 2(a) below). All such shares reported in rows 6 and 8 are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 24,313,042 shares of Common Stock, calculated as follows: (i) 49,379 shares of Common Stock subject to stock option awards that have been granted to Kirk Nielsen in his capacity as a director of the Issuer and that are exercisable as of or within 60 days of the filing of this Amendment plus (ii) 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  All such shares are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities. Percentage based on 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G


 
Vensana Capital I GP, LLC
 
Signature:/s/ Steven Schwen*
Name/Title:Steven Schwen/Attorney-in-Fact
Date:02/06/2025
 
Vensana Capital I, L.P.
 
Signature:/s/ Steven Schwen*
Name/Title:Steven Schwen/Attorney-in-Fact of Vensana Capital I GP, LLC, the General Partner of Vensana Capital I, L.P.
Date:02/06/2025
 
Kirk Nielsen
 
Signature:/s/ Steven Schwen*
Name/Title:Steven Schwen/Attorney-in-Fact
Date:02/06/2025
 
Peter Justin Klein
 
Signature:/s/ Steven Schwen*
Name/Title:Steven Schwen/Attorney-in-Fact
Date:02/06/2025

Comments accompanying signature:  *This Amendment was executed pursuant to a Power of Attorney. Note that copies of all applicable Powers of Attorney are already on file with the appropriate agencies.